Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-04991532

First Posted Date: 2011-11-10

Last Posted Date: 2012-01-31

Lead Sponsor: Pfizer

Target Recruit Count: 6

Registration Number: NCT01469481

Locations: 🇺🇸
Pfizer Investigational Site, Tacoma, Washington, United States

First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors

Phase 1

Completed

Conditions: Advanced Solid Tumors

Interventions: Drug: AG-013736

First Posted Date: 2011-11-10

Last Posted Date: 2012-03-26

Lead Sponsor: Pfizer

Target Recruit Count: 36

Registration Number: NCT01469052

Locations: 🇺🇸
Pfizer Investigational Site, Madison, Wisconsin, United States

A Study To Estimate The Effect Of Ketoconazole On The Pharmacokinetics Of Pf-04937319 In Healthy Subjects

Phase 1

Completed

Conditions: Human Volunteers

First Posted Date: 2011-11-09

Last Posted Date: 2011-11-16

Lead Sponsor: Pfizer

Target Recruit Count: 10

Registration Number: NCT01468714

Locations: 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States

A Relative BioavailabilityStudy Of Ibuprofen 40mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.

Phase 4

Completed

Conditions: Healthy

Interventions: Drug: Alivium®
Drug: Ibuprofen

First Posted Date: 2011-11-08

Last Posted Date: 2012-02-08

Lead Sponsor: Pfizer

Target Recruit Count: 70

Registration Number: NCT01466517

Locations: 🇧🇷
Pfizer Investigational Site, Aparecida de Goiania, Goias, Brazil

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Phase 3

Completed

Conditions: Ulcerative Colitis

Interventions: Drug: Placebo
Drug: tofacitinib

First Posted Date: 2011-11-06

Last Posted Date: 2016-06-07

Lead Sponsor: Pfizer

Target Recruit Count: 614

Registration Number: NCT01465763

Locations: 🇺🇸
Shafran Gastroenterology Center, Winter Park, Florida, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, Marietta, Georgia, United States
🇺🇸
GI Consultants (Colonoscopy only), Atlanta, Georgia, United States

and more 174 locations

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO

Phase 2

Completed

Conditions: Non Small Cell Lung Cancer (NSCLC)

Interventions: Drug: Dacomitinib
Drug: Doxycycline
Drug: Probiotic
Drug: Alclometasone cream

First Posted Date: 2011-11-06

Last Posted Date: 2019-01-09

Lead Sponsor: Pfizer

Target Recruit Count: 236

Registration Number: NCT01465802

Locations: 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸
St. Jude Heritage Healthcare, Fullerton, California, United States
🇺🇸
UC San Diego Medical Center - La Jolla, La Jolla, California, United States

and more 69 locations

A Study To Observe Safety And Concentrations Of PF-05297909 And Proteins In Both Blood And Cerebrospinal Fluid After A Single Dose Of PF-05297909 In Healthy Adults

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-05297909 25 mg
Drug: PF-05297909 100 mg
Drug: PF-05297909 250 mg
Drug: PF-05297909 525 mg

First Posted Date: 2011-10-31

Last Posted Date: 2012-03-13

Lead Sponsor: Pfizer

Target Recruit Count: 51

Registration Number: NCT01462851

Locations: 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Phase 2

Completed

Conditions: Meningococcal Vaccines
Vaccines

Interventions: Biological: Gardasil
Biological: rLP2086
Biological: rLP2086 and Gardasil

First Posted Date: 2011-10-28

Last Posted Date: 2018-12-19

Lead Sponsor: Pfizer

Target Recruit Count: 2499

Registration Number: NCT01461993

Locations: 🇺🇸
Rapid Medical Research, Inc., Cleveland, Ohio, United States
🇺🇸
Texas Center for Drug Development, Inc., Houston, Texas, United States
🇺🇸
Northpoint Pediatrics, LLC, Indianapolis, Indiana, United States

and more 75 locations

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Phase 2

Completed

Conditions: Vaccines
Meningococcal Vaccines

Interventions: Biological: rLP2086 + MCV4 + Tdap
Biological: MCV4 + Tdap + saline
Biological: rLP2086 + saline

First Posted Date: 2011-10-28

Last Posted Date: 2018-12-20

Lead Sponsor: Pfizer

Target Recruit Count: 2648

Registration Number: NCT01461980

Locations: 🇺🇸
The Children's Clinic of Jonesboro, PA, Jonesboro, Arkansas, United States
🇺🇸
Center for Clinical Trials, LLC, Paramount, California, United States
🇺🇸
Pediatrics and Adolescent Medicine, PA, Marietta, Georgia, United States

and more 95 locations

Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib

Completed

Conditions: GIST

Interventions: Other: non-interventional

First Posted Date: 2011-10-26

Last Posted Date: 2013-06-19

Lead Sponsor: Pfizer

Target Recruit Count: 322

Registration Number: NCT01459757

Locations: 🇮🇳
Tata Memorial Centre, Mumbai, Maharashtra, India
🇫🇮
Helsingin yliopistollinen keskussairaala/Syopatautien klinikka, Helsinki, Finland
🇺🇸
Shands Hospital at the University of Florida, Gainesville, Florida, United States

and more 33 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy